Overview
- Health care and life sciences accounted for over $5.7 billion, approximately 83% of recoveries, driven by Medicare Advantage risk adjustment, prescription drugs, and medically unnecessary or substandard care.
- Whistleblowers filed a record 1,297 qui tam suits, with roughly $5.3 billion recovered from relator matters and notable successes even where DOJ declined to intervene.
- Government-initiated health care matters rose to a record 183 new cases, even as total non‑qui tam actions across all sectors stood at 401.
- DOJ broadened use of the FCA beyond traditional billing, reporting $52 million across nine cybersecurity settlements and highlighting growing customs and tariff enforcement, including a $54.4 million duty‑evasion resolution noted as the largest of its kind.
- Several large trial judgments, including a $948.8 million ruling and a $1.6 billion verdict, are on appeal, as DOJ reiterates that timely self‑disclosure, cooperation, and remediation can earn settlement credit.